Reference - Detail
| RRC ID | 88959 |
|---|---|
| Author | Ono N, Ito Y, Aoki S, Shiohama A, Sasaki T, Kurokawa R, Suda W, Amagai M, Kubo A. |
| Title | Microbial dysbiosis and foot odor in Nagashima-type palmoplantar keratosis: Improvement with topical benzoyl peroxide. |
| Journal | J Invest Dermatol |
| Abstract |
Nagashima-type palmoplantar keratosis (also referred to as SERPINB7-related palmoplantar epidermal differentiation disorder) is the most common form of palmoplantar keratoderma in East Asia. It is characterized by erythematous hyperkeratosis, palmoplantar hyperhidrosis, and a distinctive foot odor that significantly impairs QOL. In this study, we aimed to clarify the etiology of this odor by investigating the plantar microbiome and evaluating the therapeutic effects of topical benzoyl peroxide. Compared with healthy controls, individuals with Nagashima-type palmoplantar keratosis exhibited significantly higher objective odor scores; increased bacterial load, especially in the intertoe area; and reduced microbial diversity. Corynebacterium and Staphylococcus were the predominant dysbiotic flora species. The topical application of benzoyl peroxide significantly reduced foot odor and bacterial load; increased microbial diversity; and selectively decreased Corynebacterium abundance, particularly that of C tuberculostearicum. These changes correlate with the species-specific susceptibility of skin-resident bacteria to benzoyl peroxide. Our findings suggest that microbial dysbiosis, especially the overgrowth of Corynebacterium species, is central to the pathogenesis of foot odor in Nagashima-type palmoplantar keratosis. Topical benzoyl peroxide is a promising therapeutic intervention for mitigating dysbiosis and its associated foot odor. This study highlights the potential of microbiome-targeted therapies for symptom relief in inherited skin disorders such as Nagashima-type palmoplantar keratosis. |
| Volume | 146(6) |
| Pages | 1586-1595.e5 |
| Published | 2026-6-1 |
| DOI | 10.1016/j.jid.2025.11.011 |
| PII | S0022-202X(25)03614-0 |
| PMID | 41338335 |
| MeSH | Administration, Topical Adult Benzoyl Peroxide* / administration & dosage Benzoyl Peroxide* / therapeutic use Corynebacterium / drug effects Corynebacterium / isolation & purification Dermatologic Agents* / administration & dosage Dysbiosis* / drug therapy Dysbiosis* / microbiology Female Humans Keratoderma, Palmoplantar* / complications Keratoderma, Palmoplantar* / drug therapy Keratoderma, Palmoplantar* / microbiology Male Middle Aged Odorants* / prevention & control Skin Microbiome Treatment Outcome Young Adult |
| Altmetric score |
オルトメトリクス指標項目
|
| The most frequently cited source | News |
| Total number of mentions | 14 |
| Altmetric score changes over past 6months | 57.5 |
| Resource | |
| General Microbes | JCM2414 JCM13389 |